科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688136 科兴制药

已收盘 07-30 15:00:01

{"stockData":{"symbol":"688136","market":"SH","secType":"STK","nameCN":"科兴制药","latestPrice":47.06,"timestamp":1753858801000,"preClose":50.47,"halted":0,"volume":8010332,"delay":0,"changeRate":-0.0676,"floatShares":200999999,"shares":200999999,"eps":0.2219,"marketStatus":"已收盘","change":-3.41,"latestTime":"07-30 15:00:01","open":49.8,"high":49.8,"low":46.5,"amount":386000000,"amplitude":0.0654,"askPrice":47.07,"askSize":22,"bidPrice":47.06,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.2219,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":50.47,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":55.52,"lowLimit":45.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201257250,"isCdr":false,"pbRate":5.69,"roa":"--","peRate":212.077512,"roe":"1.55%","epsLYR":0.16,"committee":-0.270936,"marketValue":9471000000,"turnoverRate":0.0398,"status":1,"afterMarket":{"amount":0,"volume":0,"close":47.06,"buyVolume":200,"sellVolume":0,"time":1753860838019,"indexStatus":"已收盘 07-30 15:30:00","preClose":50.47},"floatMarketCap":9471000000},"requestUrl":"/m/hq/s/688136","defaultTab":"news","newsList":[{"id":"2555151049","title":"科兴制药(688136.SH)股东科益医药拟询价转让3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2555151049","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555151049?lang=zh_cn&edition=full","pubTime":"2025-07-30 20:00","pubTimestamp":1753876843,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科兴制药(688136.SH)发布股东询价转让计划书，本次拟参与科兴制药首发前股东询价转让的股东为深圳科益医药控股有限公司，出让方拟转让股份的总数为603.77万股，占公司总股本的比例为3.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1574","688136","159938","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2555048392","title":"科兴制药：股东科益医药拟询价转让3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2555048392","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555048392?lang=zh_cn&edition=full","pubTime":"2025-07-30 18:41","pubTimestamp":1753872088,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","BK1515","688136","159938","BK0239","BK1161","09939"],"gpt_icon":0},{"id":"2555092937","title":"科兴制药股价下跌5.09% 限售股解禁叠加资金流出压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2555092937","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555092937?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:29","pubTimestamp":1753853371,"startTime":"0","endTime":"0","summary":"科兴制药股价大幅下跌，最新价47.90元/股，跌幅达5.09%。资金博弈加剧股价震荡科兴制药近期股价波动与多空资金激烈博弈密切相关。截至7月28日，该股近20个交易日主力资金累计净流出1.79亿元，单日最高流出超5123万元，筹码松动迹象明显。国际化成色决定估值重构长期来看，科兴制药的核心逻辑在于创新药出海战略的兑现能力。若临床数据转化不及预期，估值或面临回归压力，机构分歧下三季度将成为多空分水岭。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730132940a46ae184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730132940a46ae184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2555369099","title":"生物制品行业深度报告：多发性硬化 百亿美金市场 BTKI发展前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2555369099","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555369099?lang=zh_cn&edition=full","pubTime":"2025-07-30 00:00","pubTimestamp":1753804800,"startTime":"0","endTime":"0","summary":"MS 地理分布呈现鲜明的“纬度梯度”现象，高纬度地区发病率较高；根据Frost & Sullivan数据，全球与中国多发性硬化存量患者数量预计将在2030 年达到371/6 万人。BTK 抑制剂有望填补PMS 领域治疗空白，2025H2 数据催化密集BTK 抑制剂具有较好的血脑屏障穿透性，可通过调控B 细胞和小胶质细胞等关键免疫细胞，分别抑制炎症反应和神经退行性进程，为PMS 提供了潜在有效的治疗手段。投资建议MS 全球存量患者基数较大，存量产品市场规模约200 亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730111622a6c8dd18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730111622a6c8dd18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688428","LU1655091616.SGD","03692","LU2495084118.USD","603392","688488","BK0012","LU1997244956.HKD","688136","688336","LU2580892862.HKD","600161","LU1064131003.USD","LU2328871848.SGD","LU1064130708.USD","688276","LU2580892789.USD","688235","BK0239","LU2148510915.USD","01276","BK0188","688670","09969","688319","01952","688739","688105","BK0060","BK0196","BK0028","600276","LU0405327494.USD","600739","LU2488822045.USD","BK0183","LU1997245094.SGD","LU1969619763.USD","LU1328615791.USD","600211","LU0405327148.USD","688163","LU1997245177.USD"],"gpt_icon":0},{"id":"2555843086","title":"科兴制药涨5.00% 资金博弈与供需重构驱动股价震荡","url":"https://stock-news.laohu8.com/highlight/detail?id=2555843086","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555843086?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:30","pubTimestamp":1753756226,"startTime":"0","endTime":"0","summary":"科兴制药股价今日大幅上涨，截至10点29分，最新价为49.80元/股，涨幅达5.00%。资金博弈与供需重构驱动股价震荡科兴制药近期股价波动与资金面博弈密切相关。截至7月28日，该股近20个交易日主力资金累计净流出1.79亿元，单日最大流出金额达5123万元，筹码松动迹象明显。国际化进程与估值锚定考验成长韧性长期来看，科兴制药的核心逻辑在于创新药出海战略的兑现能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729103030a6c6e54d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729103030a6c6e54d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2554775245","title":"科兴制药提名4位非独立董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2554775245","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554775245?lang=zh_cn&edition=full","pubTime":"2025-07-28 18:22","pubTimestamp":1753698120,"startTime":"0","endTime":"0","summary":"7月28日，科兴制药（688136）发布公告，公司第二届董事会任期已满，开展董事会换届选举工作。公司第三届董事会将由8名董事组成，其中非独立董事4名、独立董事3名、职工代表董事1名。董事会同意提名邓学勤、赵彦轻、崔宁、王小琴为非独立董事候选人；同意提名 HE RUYI（何如意）、张汉斌、方俊辉独立董事候选人，其中张汉斌为会计专业人士。2025年一季度，科兴制药实现收入3.54亿元，归母净利润2558万元。（文章来源：财中社）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728185304a6c5d98d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728185304a6c5d98d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2554778073","title":"科兴制药：7月27日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2554778073","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554778073?lang=zh_cn&edition=full","pubTime":"2025-07-28 18:21","pubTimestamp":1753698062,"startTime":"0","endTime":"0","summary":"每经AI快讯，科兴制药 7月28日晚间发布公告称，公司第二届第二十七次董事会会议于2025年7月27日在深圳市南山区创益科技大厦B栋19楼会议室以现场结合通讯的方式召开。会议审议了《关于提请召开科兴生物制药股份有限公司2025年第一次临时股东大会的议案》等文件。2024年1至12月份，科兴制药的营业收入构成为：医药制造占比99.59%，其他业务占比0.25%，其他占比0.16%。截至发稿，科兴制药市值为95亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281825469723022c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281825469723022c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2554716357","title":"华创医药投资观点&研究专题周周谈·第136期：高血压创新药是一笔好生意吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554716357","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554716357?lang=zh_cn&edition=full","pubTime":"2025-07-26 00:00","pubTimestamp":1753459200,"startTime":"0","endTime":"0","summary":"本周行情回顾本周，中信医药指数上涨1.97%，跑赢沪深300指数0.28个百分点，在中信30个一级行业中排名第19位。本周涨幅前十名股票为海特生物、振东制药、塞力医疗、辰欣药业、仁度生物、康芝药业、易明医药、苑东生物、康泰医学、迈普医学。本周跌幅前十名股票*ST苏吴、永安药业、力生制药、首药控股-U、泽璟制药-U、科兴制药、信立泰、上海谊众、浙江震元、神州细胞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726164141a4647f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726164141a4647f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688197","159992","688266","603367","688513","688136","159377","600200","688091","BK0239","688193","399275","603716","688520"],"gpt_icon":0},{"id":"2553331912","title":"7月22日科兴制药跌7.54%，中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2553331912","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553331912?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:33","pubTimestamp":1753173226,"startTime":"0","endTime":"0","summary":"证券之星消息，7月22日科兴制药跌7.54%，收盘报51.13元，换手率4.77%，成交量9.6万手，成交额5.06亿元。重仓科兴制药的公募基金请见下表：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A目前规模为0.58亿元，最新净值2.0092，较上一交易日上涨1.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200026077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2553285775","title":"科兴制药跌5.10% 资金面博弈及限售股解禁预期施压","url":"https://stock-news.laohu8.com/highlight/detail?id=2553285775","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553285775?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:16","pubTimestamp":1753150569,"startTime":"0","endTime":"0","summary":"07月22日，科兴制药股价明显下行，截至10点15分，科兴制药报52.48元/股，跌幅达5.10%。资金面博弈加剧股价波动科兴制药近期股价波动与资金面博弈密切相关。控股股东6月26日减持259.77万股叠加7月21日7427万元限售股解禁预期，加剧了市场对供给端扩容的担忧。国际化战略与估值重构共振科兴制药长期逻辑锚定创新药出海战略，2024年海外收入同比增长61.96%至2.24亿元，2025年一季度外销收入再增84.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722101614a45af8a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722101614a45af8a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2552438492","title":"2025年7月17日“大众30”成份股报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2552438492","media":"大众证券报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552438492?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:16","pubTimestamp":1752758160,"startTime":"0","endTime":"0","summary":"7月17日，上证综指上涨0.37%，深证成指上涨1.43%，创业板指上涨1.76%，大众30指数上涨0.95%。大众30指数成份股中，17日涨幅前五位的分别是科兴制药、凌云光、航亚科技、蜂助手、台基股份，涨幅分别为10.14%、4.78%、4.51%、4.25%、4.22%；跌幅榜上，宁波方正、超捷股份、青木科技等跌幅居前。值得一提的是，科兴制药股价17日上涨超过一成。研究结果显示GB08安全性、耐受性良好。30指数回顾“大众30”成份股每日报告","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071723590697a9f7df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071723590697a9f7df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","399300","159982","688136"],"gpt_icon":0},{"id":"2552174242","title":"生物制品行业盘中拉升，科兴制药涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174242?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:01","pubTimestamp":1752717679,"startTime":"0","endTime":"0","summary":"07月17日，生物制品行业盘中拉升，截至10点01分，生物制品行业整体指数上涨1.00%，报6509.740点。从个股上来看，该行业的成分股中，科兴制药涨8.38%，神州细胞、智翔金泰-U2只股涨幅超过5%。从资金上来看，截止发稿，生物制品行业主力净流入为-4252.64万，其中神州细胞受到资金热捧，主力净流入6285.20万；拉长时间线来看，该板块近20日主力资金净流入-25.70亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710011997a9217f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4e7834c15c47c74e9bfd4d734ca81974","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071710011997a9217f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","688520","BK0239"],"gpt_icon":0},{"id":"2551366117","title":"动物疫苗板块持续拉升 生物股份涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551366117","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551366117?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:43","pubTimestamp":1752644582,"startTime":"0","endTime":"0","summary":"人民财讯7月16日电，动物疫苗板块持续拉升，生物股份涨停，科兴制药、瑞普生物、罗牛山、中牧股份跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071613430295446d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071613430295446d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600201","BK0028","600195","BK0077","BK0185","BK0012","688136","BK0046","BK0188","BK0196","BK0239","159646"],"gpt_icon":0},{"id":"2551112983","title":"科兴制药涨5.22% 创新药出海预期升温推动股价上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2551112983","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551112983?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:36","pubTimestamp":1752644186,"startTime":"0","endTime":"0","summary":"科兴制药股价今日大幅上涨，截至13点35分，最新价报48.41元/股，涨幅达5.22%。资金博弈加剧折射市场分歧科兴制药近期净流出主要源于多空资金激烈博弈。控股股东深圳科益医药6月26日减持259.77万股，叠加7月21日7427万元限售股解禁预期，加剧筹码松动压力。创新药出海锚定估值重构科兴制药长期逻辑围绕创新药国际化战略展开。当前股价已部分反映成长预期，后续走势需观察三季度商业化进展与资金面共振情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133633a44de654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4e7834c15c47c74e9bfd4d734ca81974","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133633a44de654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0239","688136"],"gpt_icon":0},{"id":"2551042905","title":"科兴制药内分泌领域创新药GB08长效生长激素研发新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2551042905","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551042905?lang=zh_cn&edition=full","pubTime":"2025-07-14 15:56","pubTimestamp":1752479760,"startTime":"0","endTime":"0","summary":"近日，科兴制药发表了自主研发的I类创新药项目GB08I期临床试验成果。研究结果显示GB08安全性、耐受性良好，与中国已批准上市的长效、短效生长激素比较，药效动力学指标可比，且该临床结果也为后续GB08的儿科剂量选择提供了科学依据。FC融合蛋白设计 新一代长效化方案GB08主要用于治疗儿童生长激素缺乏症，该疾病以身材矮小和代谢并发症为特征。科兴制药GB08-长效生长激素采用Fc融合蛋白长效化技术，是全新一代的蛋白药物长效化方案。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-07-14/doc-inffmpnp6562583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","688136","BK1574","BK1161","06978","BK0239"],"gpt_icon":0},{"id":"2551557919","title":"每周股票复盘：科兴制药（688136）股东减持及股权激励股份上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2551557919","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551557919?lang=zh_cn&edition=full","pubTime":"2025-07-13 03:38","pubTimestamp":1752349090,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，科兴制药报收于45.99元，较上周的49.95元下跌7.93%。股本股东变化科兴制药股东深圳科益医药控股有限公司于2025年7月7日至9日间合计减持221.42万股，占公司目前总股本的1.109%，变动期间该股股价下跌14.47%，截止7月9日收盘报42.72元。公司公告汇总科兴制药关于2024年限制性股票激励计划第一个归属期归属结果暨股份上市的公告显示，本次股票上市类型为股权激励股份，上市股数为1615000股，上市流通日期为2025年7月16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2550629729","title":"科兴制药归属162万股 将于7月16日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2550629729","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550629729?lang=zh_cn&edition=full","pubTime":"2025-07-10 20:56","pubTimestamp":1752152186,"startTime":"0","endTime":"0","summary":"7月10日，科兴制药（688136）发布公告，2024年限制性股票激励计划第一个归属期归属162万股，上市流通日期为2025年7月16日。此次股份归属的决策程序已于2024年5月及6月经过公司董事会和监事会的审议通过。根据公告，本次归属的激励对象人数为127人，归属比例为50%。公司股本总数由2亿股增加至2.01亿股，新增股份对最近一期财务报告的影响有限，预计不会对公司经营成果构成重大影响。根据2025年第一季度报告，公司的基本每股收益为0.13元/股。此次股份的归属未导致公司控股股东及实际控制人发生变更。2025年一季度，科兴制药实现收入3.54亿元，归母净利润2558万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710205724953d7a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710205724953d7a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2550661177","title":"科兴制药涨9.83%，东吴证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2550661177","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550661177?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:14","pubTimestamp":1752135296,"startTime":"0","endTime":"0","summary":"今日科兴制药涨9.83%，收盘报46.92元。2025年4月28日，东吴证券研究员朱国广发布了对科兴制药的研报《2024年报&2025年一季报点评：创新药潜力浅露头角，出海业务维持较高增速》，该研报对科兴制药给出“买入”评级。此外，开源证券研究员余汝意,汪晋，天风证券研究员杨松,曹文清近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为平安证券的臧文清。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000025062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","601555"],"gpt_icon":0},{"id":"2550622693","title":"新冠药物概念盘中拉升，科兴制药涨16.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550622693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550622693?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:12","pubTimestamp":1752113537,"startTime":"0","endTime":"0","summary":"07月10日，新冠药物概念盘中拉升，截至10点12分，新冠药物概念整体指数上涨2.04%，报713.140点。从个股上来看，该概念的成分股中，科兴制药涨16.71%，仟源医药涨幅超过10%，前沿生物-U、迈威生物-U2只股涨幅超过5%。从资金上来看，截止发稿，新冠药物概念主力净流入为2.39亿，其中仟源医药受到资金热捧，主力净流入6482.16万；拉长时间线来看，该板块近20日主力资金净流入-80.75亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710101217a4417512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710101217a4417512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2550698706","title":"动物疫苗概念盘中拉升，科兴制药涨12.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550698706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550698706?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:01","pubTimestamp":1752112883,"startTime":"0","endTime":"0","summary":"07月10日，动物疫苗概念盘中拉升，截至10点01分，动物疫苗概念整体指数上涨1.05%，报950.020点。从个股上来看，该概念的成分股中，科兴制药涨12.36%，天邦食品涨幅超过5%。从资金上来看，截止发稿，动物疫苗概念主力净流入为4432.78万，其中海正药业受到资金热捧，主力净流入3915.61万；拉长时间线来看，该板块近20日主力资金净流入-2.90亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100123a6a07d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100123a6a07d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0239","BK0188","688136","BK0028","600267","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753912269394,"stockEarnings":[{"period":"1week","weight":-0.0659},{"period":"1month","weight":0.2313},{"period":"3month","weight":0.2351},{"period":"6month","weight":1.636},{"period":"1year","weight":2.0967},{"period":"ytd","weight":1.156}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0497},{"period":"3month","weight":0.1027},{"period":"6month","weight":0.1123},{"period":"1year","weight":0.2558},{"period":"ytd","weight":0.0788}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"科兴生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8054人(较上一季度减少10.15%)","perCapita":"24988股","listingDate":"2020-12-14","address":"山东省济南市章丘区埠村街道创业路2666号","registeredCapital":"20125万元","survey":"　　科兴生物制药股份有限公司的主营业务是重组蛋白药物和微生态制剂的研发、生产、销售。公司的主要产品是依普定、赛若金、白特喜、常乐康。","listedPrice":22.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴制药,688136,科兴制药股票,科兴制药股票老虎,科兴制药股票老虎国际,科兴制药行情,科兴制药股票行情,科兴制药股价,科兴制药股市,科兴制药股票价格,科兴制药股票交易,科兴制药股票购买,科兴制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}